Revolution Medicines (RVMD) remains a "Strong Buy", driven by advanced RAS [ON] inhibitor programs and robust clinical progress, notably with Daraxonrasib. Company's phase 3 RASolute-302 trial in metastatic PDAC RAS-mutant patients is a major catalyst, with data expected in 2026 and significant expansion potential. Buyout interest from major pharma, including rumored $28–32B bids, underscores RVMD's strategic value and enhances upside optionality.

image for news Revolution Medicines: "Strong Buy" As Acquisition Prospects Continue To Circle

Gap Faces Pressure: Can Old Navy & Gap Brands Offset Athleta's Reset? — Negative

GAP   Zacks Investment Research — January 09, 2026

GAP faces Athleta's prolonged reset, but strong comps at Old Navy raise the question of whether portfolio strength can offset the drag.

image for news Gap Faces Pressure: Can Old Navy & Gap Brands Offset Athleta's Reset?

Are EV Stocks Still Worth Buying Amid Waning Sales And No More Tax Credits? — Neutral

TSLA   24/7 Wall Street — January 09, 2026

Electric vehicle stocks haven't fared well ever since the EV tax credit expired on September 30, 2025.

image for news Are EV Stocks Still Worth Buying Amid Waning Sales And No More Tax Credits?

3 Stocks That Benefit if Companies Cut Costs in 2026 — Neutral

ADP  BILL  PAYC   MarketBeat — January 09, 2026

We are entering a new earnings season. Earnings reports are crucial to understanding a company's outlook for revenue and profit in the coming quarters, especially as headwinds still exist in many sectors of the economy.

image for news 3 Stocks That Benefit if Companies Cut Costs in 2026

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ARDENT HEALTH, INC. (ARDT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 12, 2025, after market hours, Ardent released its third.

image for news Securities Fraud Investigation Into Ardent Health, Inc. (ARDT) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Joby to Benefit From Second Ohio Facility Acquisition: Here's How — Positive

JOBY   Zacks Investment Research — January 09, 2026

JOBY plans to double aircraft output by 2027 after buying a 700,000-square-foot Dayton facility, expanding Ohio operations and near-term capacity.

image for news Joby to Benefit From Second Ohio Facility Acquisition: Here's How

Jazz Pharmaceuticals plc (JAZZ) Discusses HERIZON-GEA-01 Phase III Trial Results for Zanidatamab in HER2+ GEA Transcript

image for news Jazz Pharmaceuticals plc (JAZZ) Discusses HERIZON-GEA-01 Phase III Trial Results for Zanidatamab in HER2+ GEA Transcript

What to know about Meta's big nuclear deals — Neutral

META   CNBC Television — January 09, 2026

CNBC's Julia Boorstin reports on Meta's nuclear deals.

image for news What to know about Meta's big nuclear deals

If there was an oil supply glut, prices would be collapsing: Carlyle's Currie — Neutral

BNO  CG  DBO  GUSH  IEO  OIH  OIL  PXJ  UCO  USO  XOP   CNBC Television — January 09, 2026

CNBC's "The Exchange" team discusses commodities, including gold and oil, as well as President Trump's meeting with oil companies about Venezuela with Jeffrey Currie of the Carlyle Group.

image for news If there was an oil supply glut, prices would be collapsing: Carlyle's Currie

S&P 500 Holds Its Bullish Pattern as the Elliott Waves Forecast 7300+ — Positive

IVV  SPLG  SPXL  SPY  SSO  UPRO  VOO   FXEmpire — January 09, 2026

The Elliott wave indicates the index is in a 3rd wave, with an ideal target of approximately 7250, followed by a 4th-wave pullback to ~7100 and another 5th-wave rally to approximately 7345-7490.

image for news S&P 500 Holds Its Bullish Pattern as the Elliott Waves Forecast 7300+

Stellantis scraps US plug-in hybrid sales, citing weak demand — Negative

STLA   Reuters — January 09, 2026

Chrysler parent Stellantis said on Friday it will stop selling plug-in hybrid versions of the Jeep Wrangler and Grand Cherokee, and the Chrysler Pacifica minivan, in the United States as it navigates soft demand and shifts its North American electrification strategy.

image for news Stellantis scraps US plug-in hybrid sales, citing weak demand

Meta signed agreements with three nuclear energy companies to help power its artificial intelligence-focused data centers.

image for news Meta Signs Deals With 3 Nuclear Energy Companies to Power Data Centers

ATLANTA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (NASDAQ: AQST) complied with federal securities laws. On January 9, 2026, Aquestive disclosed that it received a notice from the FDA that it “had identified deficiencies in the New Drug Application (NDA) submitted by the Company for its product candidate, Anaphylm™ (epinephrine) Sublingual Film, for the treatment of severe allergic reactions, including anaphylaxis, that preclude discussion of labeling and post-marketing commitments for Anaphylm.” Following this news, the price of the Company's stock dropped.

image for news INVESTOR ALERT: Investigation of Aquestive Therapeutics, Inc. (AQST) by Holzer & Holzer, LLC

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Capital Link is hosting a series of online Company Presentations, during which the Senior Management teams of leading publicly listed maritime companies will present their business development, strategy, growth prospects, and overall sector outlook. On Wednesday, January 14, 2026, at 10:00 AM ET, Scorpio Tankers Inc. (NYSE: STNG) will kick off Capital Link's 2026 Virtual Corporate Presentation Series, which will continue in the weeks that follow with presentations by senior management teams from additional leading publicly listed maritime companies.

image for news Scorpio Tankers Inc. Kicks Off Capital Link's 2026 Virtual Company Presentation Series

Intel's stock hit its highest point in nearly two years Friday, thanks to a social media post.

image for news Here's What President Trump Said About Intel's CEO That's Boosting the Stock Friday

San Diego, California--(Newsfile Corp. - January 9, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Klarna Group plc (NYSE: KLAR) securities pursuant and/or traceable to Klarna's offering documents issued in connection with Klarna's September 10, 2025 initial public offering (the "IPO"), have until February 20, 2026 to seek appointment as lead plaintiff of the Klarna class action lawsuit. Captioned Nayak v.

image for news KLAR INVESTOR DEADLINE: Klarna Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

iPhone 17 Demand Lifts AAPL Supercycle, AI & Innovation "Question Mark" — Positive

AAPL   Schwab Network — January 09, 2026

The holiday season added muscle to Apple's (AAPL) iPhone 17 sales. @LikeFolio's data shows strong demand in the tail-end of 2025, something Megan Brantley believes offers a good set-up for 2026.

image for news iPhone 17 Demand Lifts AAPL Supercycle, AI & Innovation "Question Mark"

CANTON, Ga., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the release of two new home designs at Aurora Ridge at Great Sky, a premier community by Toll Brothers in the scenic hills of Cherokee County, Georgia.

image for news Toll Brothers Announces the Release of New Ranch Home Designs at Aurora Ridge at Great Sky in Canton, Georgia

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming January 12, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON STRIDE, INC. (LRN), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD.

image for news Deadline Soon: Stride, Inc. (LRN) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Olin: Shares Brush Off A Negative Preannouncement — Negative

OLN   Seeking Alpha — January 09, 2026

Olin Corporation remains a "Buy" as shares trade at a compressed ~9x mid-cycle earnings, despite recent operational setbacks. The Q4 EBITDA miss is primarily due to one-time maintenance overruns at Freeport; operations have since normalized, but capex may need to rise to sustainable levels. Demand headwinds persist, especially from weak Chinese and U.S. construction, with 2026 results expected to be flat or slightly lower versus 2025.

image for news Olin: Shares Brush Off A Negative Preannouncement